EGFR-Targeted Therapeutics: Focus on SCCHN and NSCLC

@inproceedings{Sattler2008EGFRTargetedTF,
  title={EGFR-Targeted Therapeutics: Focus on SCCHN and NSCLC},
  author={Martin Sattler and Oyewale Abidoye and Ravi Salgia},
  booktitle={TheScientificWorldJournal},
  year={2008}
}
Cancers of the head and neck and of the lung are associated with high morbidity and mortality rates that have remained relatively unchanged for more than 3 decades, despite advances in radiation therapies and chemotherapies over the same time. It is generally believed that the efficacy of standard therapy regimens has reached a plateau for these cancers. The discovery of specific aberrant molecular signaling pathways in solid tumors has afforded promising new directions for newer "targeted… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 56 references

Epidermal growth factor receptor (EGFR) signaling in cancer

  • N. Normanno, A. De Luca, C Bianco
  • Gene 366,
  • 2006
Highly Influential
3 Excerpts

with refractory advanced non - small - cell lung cancer : results from a randomised , placebo - controlled , multicentre study ( Iressa Survival Evaluation in Lung Cancer )

  • K. Kelly, K. Chansky, L. E. Gaspar
  • 2008

A phase II study of cetuximab (C225) in combination with chemoradiation (CRT) in patients (pts) with stage III A/B non-small cell lung cancer (NSCLC): an interim report of the RTOG 0324 trial

  • G. Blumenschein, Jr., J. Moughan, W Curran
  • J Clin Oncol (Meeting Abstracts)
  • 2007
1 Excerpt

Cetuximab (C-mab) and chemo-radiation (CT-RT) for locoregional advanced squamous cell carcinoma of the head and neck (HNC): a phase II study

  • M. C. Merlano, G. Numico, Russi, E.G
  • J. Clin. Oncol. (Meeting Abstracts)
  • 2007
1 Excerpt

Cetuximab extends survival of patients with recurrent or metastatic SCCHN when added to first line platinum based therapy. Results of a randomized phase III (Extreme) study

  • J. B. Vermorken, R. Mesia, V Vega
  • J. Clin. Oncol. (Meeting Abstracts)
  • 2007
1 Excerpt

Similar Papers

Loading similar papers…